PerkinElmer SCID-SMA Kit Gets FDA Authorization
PerkinElmer has announced that the FDA has authorized the marketing of the EONIS SCID-SMA assay kit for the diagnosis of SMA and SCID.
Read MorePosted by Chris Wolski | Nov 14, 2022 | Immunoassay Reagents & test Kits |
PerkinElmer has announced that the FDA has authorized the marketing of the EONIS SCID-SMA assay kit for the diagnosis of SMA and SCID.
Read MorePosted by Chris Wolski | Nov 11, 2022 | Prenatal Testing |
Cedars-Sinai investigators have found that a specific imbalance of two placental proteins could predict preeclampsia risk.
Read MorePosted by Chris Wolski | Nov 9, 2022 | Biochemicals & Chemical Reagents |
PCR Biosystems has launched a new family of qPCR reagents mixes: Clara Probe Mix, Clara Probe 1-Step Mix and Clara HRM Mix.
Read MorePosted by Chris Wolski | Nov 9, 2022 | Gastrointestinal Infections |
ProciseDx Inc. announces it has received FDA clearance for its ProciseDx instrument and C reactive Protein (CRP) test.
Read MorePosted by Chris Wolski | Nov 9, 2022 | Molecular Diagnostic Analyzers |
UK diagnostics manufacturer, Llusern Scientific, will preview its Lodestar DX molecular diagnostic platform at the upcoming Medica 2022.
Read More